Table 3 Postoperative outcomes according to the study groups
Variable | Non-AKI group (n = 97) | AKI without HB group (n = 119) | HB-AKI group (n = 68) | P |
|---|---|---|---|---|
Sepsis | 2 (2.1%) | 6 (5.0%) | 7 (10.3%) | 0.071 |
Re-exploration for bleeding | 5 (5.2%) | 12 (10.1%) | 4 (5.9%) | 0.400 |
CRRT | 0 (0) | 58 (48.7%) | 41 (60.3%) | < 0.001 |
Tracheotomy | 7 (7.2%) | 25 (21.0%) | 16 (23.5%) | 0.004 |
ECMO | 0 (0) | 2 (1.7%) | 0 (0) | 0.511 |
Stroke | 1 (1.0%) | 4 (3.4%) | 4 (5.9%) | 0.209 |
AKI class | < 0.001 | |||
AKI1 | 0 (0) | 26 (21.8%) | 6 (8.8%) | |
AKI2 | 0 (0) | 27 (22.7%) | 10 (14.7%) | |
AKI3 | 0 (0) | 66 (55.5%) | 52 (76.5%) | |
Postoperative laboratory characteristics | ||||
Peak AST, IU/L | 60.0 (40.9–92.0) | 92.0 (56.0–213.0) | 189.5 (71.0–545) | 0.011 |
Peak ALT, IU/L | 42.0 (29.3–77.5) | 67.0 (35.0–124.1) | 119.9 (45.0–428.5) | 0.022 |
Peak total bilirubin, μmol/L | 38.7 (25.8–51.2) | 31.9 (24.8–43.0) | 69.9 (59.0–98.8) | < 0.001 |
Peak sCr, μmol/L | 101.0 (86.6–130.0) | 204.0 (135.3–358.9) | 253.8 (176.8–329.7) | < 0.001 |
Peak BUN, μmol/L | 13.2 (10.8–16.5) | 19.2 (15.0–26.2) | 20.8 (14.3–30.2) | < 0.001 |
30-day death | 4 (4.1%) | 10 (8.4%) | 11 (16.2%) | 0.024 |
Mechanical ventilation time, h | 24.0 (20.0–60.0) | 72.0 (24.0–144.0) | 72.5 (48.0–187.5) | < 0.001 |
Hospital stay, d | 23.0 (19.0–32.0) | 25.5 (20.0–38.0) | 28.0 (17.0–44.0) | 0.049 |
CKD | 6 (6.2%) | 21 (17.6%) | 19 (27.9%) | 0.001 |